1. Devine JF (2008) Chronic obstructive pulmonary disease: an overview. Am Health Drug Benefits 1(7):34–42
2. https://www.who.int/respiratory/copd/burden/en/ Date accessed: 15.09.20
3. Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health (US) (2010) How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Centers for Disease Control and Prevention (US), Atlanta, GA. 7, Pulmonary Diseases. Available from: https://www.ncbi.nlm.nih.gov/books/NBK53021/ Date accessed: 15.09.20
4. Hersh CP, Campbell EJ, Scott LR, Raby BA (2019) Alpha-1 antitrypsin deficiency as an incidental finding in clinical genetic testing. Am J Respir Crit Care Med 199(2):246–248
5. Tasch JJ, McLaughlan AT, Nasir AA (2018) A novel approach to screening for Alpha-1 antitrypsin deficiency: inpatient testing at a teaching institution. Chronic Obstr Pulm Dis 5(2):106–110